BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30631150)

  • 41. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).
    Leverson JD; Zhang H; Chen J; Tahir SK; Phillips DC; Xue J; Nimmer P; Jin S; Smith M; Xiao Y; Kovar P; Tanaka A; Bruncko M; Sheppard GS; Wang L; Gierke S; Kategaya L; Anderson DJ; Wong C; Eastham-Anderson J; Ludlam MJ; Sampath D; Fairbrother WJ; Wertz I; Rosenberg SH; Tse C; Elmore SW; Souers AJ
    Cell Death Dis; 2015 Jan; 6(1):e1590. PubMed ID: 25590800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dioscin induces caspase-independent apoptosis through activation of apoptosis-inducing factor in breast cancer cells.
    Kim EA; Jang JH; Lee YH; Sung EG; Song IH; Kim JY; Kim S; Sohn HY; Lee TJ
    Apoptosis; 2014 Jul; 19(7):1165-75. PubMed ID: 24771279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cafestol overcomes ABT-737 resistance in Mcl-1-overexpressed renal carcinoma Caki cells through downregulation of Mcl-1 expression and upregulation of Bim expression.
    Woo SM; Min KJ; Seo BR; Nam JO; Choi KS; Yoo YH; Kwon TK
    Cell Death Dis; 2014 Nov; 5(11):e1514. PubMed ID: 25375379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode.
    Hedir S; De Giorgi M; Fogha J; De Pascale M; Weiswald LB; Brotin E; Marekha B; Denoyelle C; Denis C; Suzanne P; Gautier F; Juin P; Ligat L; Lopez F; Carlier L; Legay R; Bureau R; Rault S; Poulain L; Oliveira Santos JS; Voisin-Chiret AS
    Eur J Med Chem; 2018 Nov; 159():357-380. PubMed ID: 30308410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of apoptosis by VB1 in breast cancer cells: the role of reactive oxygen species and Bcl-2 family proteins.
    Liu LH; Zhou YJ; Ding L; Zhang SZ; Sun J; Cao JG
    Int J Mol Med; 2014 Feb; 33(2):423-30. PubMed ID: 24276280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells.
    Zhao J; Niu X; Li X; Edwards H; Wang G; Wang Y; Taub JW; Lin H; Ge Y
    Oncotarget; 2016 Jun; 7(23):34785-99. PubMed ID: 27166183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene.
    Eguchi H; Suga K; Saji H; Toi M; Nakachi K; Hayashi SI
    Cell Death Differ; 2000 May; 7(5):439-46. PubMed ID: 10800077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
    Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
    Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion.
    Young AI; Timpson P; Gallego-Ortega D; Ormandy CJ; Oakes SR
    Cell Adh Migr; 2018; 12(6):513-523. PubMed ID: 29166822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation.
    Romano V; Ruocco MR; Carotenuto P; Barbato A; Venuta A; Acampora V; De Lella S; Vigliar E; Iaccarino A; Troncone G; Calì G; Insabato L; Russo D; Franco B; Masone S; Velotti N; Accurso A; Pellegrino T; Fiume G; Belviso I; Montagnani S; Avagliano A; Arcucci A
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nutrient Deprivation Promotes MCL-1 Degradation in an Autophagy-Independent Manner.
    Pervushin NV; Senichkin VV; Kapusta AA; Gorbunova AS; Kaminskyy VO; Zhivotovsky B; Kopeina GS
    Biochemistry (Mosc); 2020 Oct; 85(10):1235-1244. PubMed ID: 33202208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delivery of Cas13a/crRNA by self-degradable black phosphorus nanosheets to specifically inhibit Mcl-1 for breast cancer therapy.
    Yue H; Huang R; Shan Y; Xing D
    J Mater Chem B; 2020 Dec; 8(48):11096-11106. PubMed ID: 33210699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discussion.
    Surgery; 2019 Oct; 166(4):522-523. PubMed ID: 31301869
    [No Abstract]   [Full Text] [Related]  

  • 54. Potent and Selective PTDSS1 Inhibitors Induce Collateral Lethality in Cancers with PTDSS2 Deletion.
    Yoshihama Y; Namiki H; Kato T; Shimazaki N; Takaishi S; Kadoshima-Yamaoka K; Yukinaga H; Maeda N; Shibutani T; Fujimoto K; Hirasawa M; Goto H; Wada N; Tsutsumi S; Hirota Y; Ishikawa T; Yamamoto S
    Cancer Res; 2022 Nov; 82(21):4031-4043. PubMed ID: 36054550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis.
    Ishay-Ronen D; Diepenbruck M; Kalathur RKR; Sugiyama N; Tiede S; Ivanek R; Bantug G; Morini MF; Wang J; Hess C; Christofori G
    Cancer Cell; 2019 Jan; 35(1):17-32.e6. PubMed ID: 30645973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma.
    Bae CA; Ham IH; Oh HJ; Lee D; Woo J; Son SY; Yoon JH; Lorens JB; Brekken RA; Kim TM; Han SU; Park WS; Hur H
    Gastric Cancer; 2020 Sep; 23(5):824-836. PubMed ID: 32239298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling.
    Zhou Z; Zhou Q; Wu X; Xu S; Hu X; Tao X; Li B; Peng J; Li D; Shen L; Cao Y; Yang L
    Cancer Lett; 2020 Mar; 473():62-73. PubMed ID: 31904479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nuclear factor-κB activation by transforming growth factor-β1 drives tumour microenvironment-mediated drug resistance in neuroblastoma.
    Louault K; Blavier L; Lee MH; Kennedy RJ; Fernandez GE; Pawel BR; Asgharzadeh S; DeClerck YA
    Br J Cancer; 2024 May; ():. PubMed ID: 38806726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: insights into apoptosis, autophagy, ferroptosis, and pyroptosis.
    Chen C; Liu J; Lin X; Xiang A; Ye Q; Guo J; Rui T; Xu J; Hu S
    Cell Death Discov; 2024 Apr; 10(1):189. PubMed ID: 38649701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy.
    Hulo P; Deshayes S; Fresquet J; Chéné AL; Blandin S; Boisgerault N; Fonteneau JF; Treps L; Denis MG; Bennouna J; Fradin D; Pons-Tostivint E; Blanquart C
    Respir Res; 2024 Apr; 25(1):156. PubMed ID: 38581044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.